Jan 28 2011 | 12:08pm ET
A group of Human Genome Sciences investors has sued the hedge fund, alleging that the firm used nonpublic information to skirt $30 million in losses in 2007 and 2008.
Jul 8 2014 | 10:48am ET
The surge in derivatives regulation is among the most complex challenges facing the financial services industry today. Northern Trust’s Joshua Satten recently spoke with FINalternatives to share insights into the challenges presented by new regulation and explore how the industry is responding. Read more…